Annual CFI
$60.00 M
-$1.02 B-94.43%
31 December 2023
Summary:
BeiGene annual cash flow from investing activities is currently $60.00 million, with the most recent change of -$1.02 billion (-94.43%) on 31 December 2023. During the last 3 years, it has risen by +$3.23 billion (+101.89%). BGNE annual CFI is now -94.43% below its all-time high of $1.08 billion, reached on 31 December 2022.BGNE Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$133.88 M
-$22.85 M-20.58%
30 September 2024
Summary:
BeiGene quarterly cash flow from investing activities is currently -$133.88 million, with the most recent change of -$22.85 million (-20.58%) on 30 September 2024. Over the past year, it has increased by +$52.39 million (+28.13%). BGNE quarterly CFI is now -120.32% below its all-time high of $658.71 million, reached on 30 June 2022.BGNE Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$517.33 M
+$52.39 M+9.20%
30 September 2024
Summary:
BeiGene TTM cash flow from investing activities is currently -$517.33 million, with the most recent change of +$52.39 million (+9.20%) on 30 September 2024. Over the past year, it has dropped by -$678.45 million (-421.08%). BGNE TTM CFI is now -145.08% below its all-time high of $1.15 billion, reached on 30 September 2022.BGNE TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BGNE Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -94.4% | +28.1% | -421.1% |
| 3 y3 years | +101.9% | -1016.1% | -216.3% |
| 5 y5 years | +109.4% | -162.7% | -165.4% |
BGNE Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -94.4% | +101.9% | -120.3% | +36.2% | -145.1% | +9.2% |
| 5 y | 5 years | -94.4% | +101.9% | -120.3% | +91.3% | -145.1% | +83.7% |
| alltime | all time | -94.4% | +101.9% | -120.3% | +91.3% | -145.1% | +83.7% |
BeiGene Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$133.88 M(+20.6%) | -$517.33 M(-9.2%) |
| June 2024 | - | -$111.03 M(-47.1%) | -$569.72 M(+45.7%) |
| Mar 2024 | - | -$209.83 M(+235.3%) | -$390.89 M(-751.4%) |
| Dec 2023 | $60.00 M(-94.4%) | -$62.58 M(-66.4%) | $60.00 M(-62.8%) |
| Sept 2023 | - | -$186.28 M(-374.7%) | $161.12 M(-68.8%) |
| June 2023 | - | $67.80 M(-71.9%) | $516.88 M(-53.3%) |
| Mar 2023 | - | $241.06 M(+525.6%) | $1.11 B(+2.8%) |
| Dec 2022 | $1.08 B(+68.1%) | $38.54 M(-77.3%) | $1.08 B(-6.1%) |
| Sept 2022 | - | $169.48 M(-74.3%) | $1.15 B(+18.8%) |
| June 2022 | - | $658.71 M(+213.1%) | $966.22 M(+72.8%) |
| Mar 2022 | - | $210.39 M(+92.8%) | $559.10 M(-12.7%) |
| Dec 2021 | $640.66 M(-120.2%) | $109.11 M(-1009.6%) | $640.66 M(+44.1%) |
| Sept 2021 | - | -$11.99 M(-104.8%) | $444.62 M(-141.2%) |
| June 2021 | - | $251.60 M(-13.8%) | -$1.08 B(-38.7%) |
| Mar 2021 | - | $291.95 M(-435.9%) | -$1.76 B(-44.4%) |
| Dec 2020 | -$3.17 B(-671.7%) | -$86.92 M(-94.3%) | -$3.17 B(+2.0%) |
| Sept 2020 | - | -$1.54 B(+257.4%) | -$3.11 B(+129.2%) |
| June 2020 | - | -$429.89 M(-61.4%) | -$1.36 B(+84.8%) |
| Mar 2020 | - | -$1.11 B(+4566.7%) | -$733.22 M(-232.3%) |
| Dec 2019 | $554.16 M | -$23.89 M(-111.2%) | $554.16 M(-30.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $213.63 M(+11.3%) | $791.30 M(+809.2%) |
| June 2019 | - | $192.01 M(+11.4%) | $87.03 M(-222.8%) |
| Mar 2019 | - | $172.42 M(-19.1%) | -$70.84 M(-88.9%) |
| Dec 2018 | -$637.61 M(+78.9%) | $213.24 M(-143.5%) | -$637.61 M(-30.6%) |
| Sept 2018 | - | -$490.64 M(-1537.5%) | -$919.10 M(+10.8%) |
| June 2018 | - | $34.13 M(-108.7%) | -$829.79 M(+4.5%) |
| Mar 2018 | - | -$394.35 M(+477.9%) | -$794.21 M(+122.9%) |
| Dec 2017 | -$356.32 M(+60.6%) | -$68.24 M(-83.0%) | -$356.32 M(-22.3%) |
| Sept 2017 | - | -$401.33 M(-675.7%) | -$458.80 M(+3325.4%) |
| June 2017 | - | $69.71 M(+60.1%) | -$13.39 M(-93.9%) |
| Mar 2017 | - | $43.54 M(-125.5%) | -$218.65 M(-1.4%) |
| Dec 2016 | -$221.85 M(+276.6%) | -$170.72 M(-487.3%) | -$221.85 M(+406.2%) |
| Sept 2016 | - | $44.08 M(-132.5%) | -$43.83 M(-46.3%) |
| June 2016 | - | -$135.55 M(-436.0%) | -$81.65 M(+274.6%) |
| Mar 2016 | - | $40.34 M(+452.5%) | -$21.79 M(-63.0%) |
| Dec 2015 | -$58.91 M(+75.1%) | $7.30 M(+16.8%) | -$58.91 M(-11.0%) |
| Sept 2015 | - | $6.25 M(-108.3%) | -$66.21 M(-8.6%) |
| June 2015 | - | -$75.69 M(-2442.7%) | -$72.46 M(-2342.7%) |
| Mar 2015 | - | $3.23 M | $3.23 M |
| Dec 2014 | -$33.64 M(>+9900.0%) | - | - |
| Dec 2013 | -$250.00 K | - | - |
FAQ
- What is BeiGene annual cash flow from investing activities?
- What is the all time high annual CFI for BeiGene?
- What is BeiGene annual CFI year-on-year change?
- What is BeiGene quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for BeiGene?
- What is BeiGene quarterly CFI year-on-year change?
- What is BeiGene TTM cash flow from investing activities?
- What is the all time high TTM CFI for BeiGene?
- What is BeiGene TTM CFI year-on-year change?
What is BeiGene annual cash flow from investing activities?
The current annual CFI of BGNE is $60.00 M
What is the all time high annual CFI for BeiGene?
BeiGene all-time high annual cash flow from investing activities is $1.08 B
What is BeiGene annual CFI year-on-year change?
Over the past year, BGNE annual cash flow from investing activities has changed by -$1.02 B (-94.43%)
What is BeiGene quarterly cash flow from investing activities?
The current quarterly CFI of BGNE is -$133.88 M
What is the all time high quarterly CFI for BeiGene?
BeiGene all-time high quarterly cash flow from investing activities is $658.71 M
What is BeiGene quarterly CFI year-on-year change?
Over the past year, BGNE quarterly cash flow from investing activities has changed by +$52.39 M (+28.13%)
What is BeiGene TTM cash flow from investing activities?
The current TTM CFI of BGNE is -$517.33 M
What is the all time high TTM CFI for BeiGene?
BeiGene all-time high TTM cash flow from investing activities is $1.15 B
What is BeiGene TTM CFI year-on-year change?
Over the past year, BGNE TTM cash flow from investing activities has changed by -$678.45 M (-421.08%)